Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT
NCT04291196
Anxiety, Anxiety Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT Number: NCT03135756
Eligible participants will come in for three separate visits in which they will be interviewed, perform a variety of tasks, and undergo a non-invasive MRI scan. The investigators anticipate that (1) participants with anxiety and depression will likely perform differently than the healthy controls on cognitive tasks, (2) participants with anxiety and depression will likely show differences in brain functionality compared to the healthy controls, and (3) depression and anxiety likely share some underlying mechanisms.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Observational
Palo Alto University, Los Altos, California, United States
In order to determine eligibility, a brief phone screen lasting approximately 15 minutes will be conducted. If participants are eligible, they will be asked to come in for three separate visits. During the first visit, participants will complete questionnaires as well as a structured interview with one of the study's staff members at Palo Alto University in Los Altos. During the second visit, participants would come to Palo Alto University in Los Altos and complete questionnaires as well as a testing session involving various tasks. During the third visit, participants would undergo a non-invasive brain scan in which participants would complete a task as well as various questionnaires at Stanford University in Stanford.
The investigators have flexible hours and can work around participants' schedules! To inquire more about participation, participants can either email the investigators at [email protected] or call the investigators at (650) 417-2000 ext. 3642
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: Day 1
Non-invasive MRI brain scan to see function and structure of brain
Time frame: Day 1
Structured Clinical Interview for DSM-IV, General demographic questionnaires, Penn State Worry Questionnaire, Intolerance of Uncertainty Questionnaire, The Positive and Negative Affect Schedule, Behavioral Inhibition Scale/Behavioral Activation Scale, The NEO Five-Factor Inventory, Mood and Anxiety Symptom Questionnaire, Alcohol Use Disorders Identification Test, Behavioral Regulation Index and Metacognition Index, General temperament Survey, Questionnaire of Mental Imagery, Rumination Reflection Questionnaire, Drug Abuse Screening Test, Childhood Trauma Questionnaire- Factor Structure, Emotion Regulation Questionnaire, Trait Meta-Mood Scale
Time frame: Day 1
Objective assessment of cognitive strengths and weaknesses via neuropsychological testing session
Palo Alto University
Other
Transdiagnostic Endophenotypes of Anxiety and Depression
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04291196
Anxiety, Anxiety Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT07760701
Anxiety, Anxiety Disorders
Lusaka, Lusaka Province, Zambia
View Trial DetailsNCT06993662
Anxiety, Anxiety Disorders
Athens, Greece
View Trial DetailsNCT07741422
Anxiety, Anxiety Disorders
Guangzhou, Guangdong, China
View Trial Details